Updated definitions of adverse events for trials and registries of mechanical circulatory support: A consensus statement of the mechanical circulatory support academic research consortium

Over 25 years ago, it became clear that heart transplantation would become a treatment option for only a limited group of carefully selected patients with advanced heart failure (HF) because of limited donor heart organ availability and restrictive transplant eligibility criteria. 1 Hsich EM Matching the market for heart transplantation. Circ Heart Fail. 2016; 9e002679 Crossref PubMed Scopus (60) Google Scholar This reality energized research...